Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Avanir: Initiation of Phase 3 Trial of AVP-786 for Agitation in Alzheimer’s

November 16, 2015 11:42 am | News | Comments

Avanir Pharmaceuticals, Inc. today announced initiation of enrollment into a phase 3 clinical trial evaluating AVP-786 for the treatment of agitation in patients with Alzheimer’s disease. This is the first of two placebo-controlled phase 3 trials in the company’s TRIAD program. Read more...


Gilead's Zydelig Combination Shows Superior Efficacy in Phase 3 CLL Study

November 16, 2015 11:36 am | News | Comments

Following the recommendation by an independent Data Monitoring Committee (DMC), Gilead Sciences, Inc. today announced that its Phase 3 Study 115 evaluating Zydelig® (idelalisib) added to standard therapy in previously-treated chronic lymphocytic leukemia (CLL) patients will be unblinded early. Read more..


Alimera: 36-Month Analysis That Shows Iluvien Slows Diabetic Retinopathy

November 16, 2015 11:27 am | News | Comments

Alimera Sciences, Inc.(Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that a new analysis of patients from the FAME Study demonstrated a significant slowing of the progression of diabetic retinopathy (DR) in patients with diabetic macular edema (DME) treated with Iluvien. Read more...


Child with Drug-Resistant TB Successfully Treated at Johns Hopkins Children's Center

November 16, 2015 9:41 am | by Johns Hopkins University | News | Comments

Johns Hopkins Children's Center specialists report they have successfully treated and put in remission a 2-year-old, now age 5, with a highly virulent form of tuberculosis known as XDR TB, or extensively drug-resistant TB. Read more...


Cannabis-Derived Drugs to Target Diabetic Kidney Failure

November 16, 2015 8:56 am | by University of Aberdeen | News | Comments

Approximately 40 percent of people with diabetes develop kidney failure (diabetic nephropathy) as a result. Read more...

Rare TB Case Shows Diagnosing, Treating Children is Tough

November 16, 2015 8:41 am | by Lauren Neergaard, AP Medical Writer | News | Comments

Drug-resistant tuberculosis is a global health threat, and it's particularly challenging for young children who are harder even to diagnose, much less treat.


Gene Therapy: A Promising Candidate for Cystic Fibrosis Treatment

November 16, 2015 8:34 am | by KU Leuven | News | Comments

An improved gene therapy treatment can cure mice with cystic fibrosis (CF). Read more...


Roche to Cut Thousands of Jobs in U.S., Europe

November 16, 2015 7:15 am | by Ryan Bushey, Associate Editor | News | Comments

This change requires the company to close one plant in Florence, South Carolina, and three more overseas in Spain, Ireland, and Italy. Read more...


Global Prostate Cancer Treatment Market to Reach $13.6B by 2021

November 16, 2015 7:00 am | by Katie Noon, Senior Analyst, GBI Research | News | Comments

The continued uptake of Zytiga and Xtandi and the approval of several premium products will also be key factors aiding prostate cancer therapy market growth by 2021. Read more...


Clinical Trial Results Disclosure by Large Biopharmaceuticals Falls Below Legal, Ethical Standards: BMJ Study

November 13, 2015 11:10 am | News | Comments

Bioethics International, a not-for-profit organization focused on the ethics and governance of how medicines are researched, developed, marketed and made accessible to patients around the world, today announced the publication of a study ranking large pharmaceutical companies by transparency of clinical trial results in BMJ Open. Read more...


Experimental Drug Targeting Alzheimer's Disease Shows Anti-Aging Effects

November 13, 2015 11:05 am | by Salk Institute | News | Comments

Salk Institute researchers have found that an experimental drug candidate aimed at combating Alzheimer’s disease has a host of unexpected anti-aging effects in animals. Read more...


Rite Aid Adds Prescription Analysis to Genetic Test Lineup

November 13, 2015 11:00 am | by Tom Murphy, AP Business Writer | News | Comments

Rite Aid is giving patients a chance to peek over their doctor's shoulder with genetic tests that help determine the effectiveness of some prescriptions. Read more...


Melanoma’s Genetic Trajectories Are Charted in New Study

November 13, 2015 10:55 am | by University of California, San Francisco | News | Comments

An international team of scientists led by UC San Francisco researchers has mapped out the genetic trajectories taken by melanoma as it evolves from early skin lesions, known as precursors, to malignant skin cancer, which can be lethal when it invades other tissues in the body. Read more...


Drug Discovery Spotlight: Valeant Update; Rise in Autism Diagnoses; Uterine Transplants

November 13, 2015 10:40 am | by Stephanie Guzowski, Editor | News | Comments

Welcome to Drug Discovery Spotlight, where we’ve rounded up this week’s trending headlines. Read more...


Comprehensive Range of Lentivirus for Gene & shRNA Delivery

November 13, 2015 9:24 am | by AMSBIO | Product Releases | Comments

AMSBIO offers a comprehensive range of more than 54,000 lentivirus for shRNA delivery. To make selection of the optimum lentivirus quick and easy, AMSBIO has developed an online search tool** where you need simply enter your target gene symbol or a key word. Lentivirus is a subfamily of the retrovirus family. Lentiviruses can deliver significant amounts of genetic information into host cell...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.